Reaction Details Report a problem with these data
Target
Uracil nucleotide/cysteinyl leukotriene receptor
Ligand
BDBM646601
Substrate
n/a
Meas. Tech.
GPR17 cAMP Assay Protocol
IC50
7.00±n/a nM
Citation
 GALLEY, G; GOBBI, L; GUBA, W; MAZUNIN, D; PINARD, E; RICCI, A PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES US Patent  US20240025883 Publication Date 1/25/2024 
Target
Name:
Uracil nucleotide/cysteinyl leukotriene receptor
Synonyms:
GPR17 | GPR17_HUMAN
Type:
PROTEIN
Mol. Mass.:
41013.71
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1353471
Residue:
367
Sequence:
MSKRSWWAGSRKPPREMLKLSGSDSSQSMNGLEVAPPGLITNFSLATAEQCGQETPLENMLFASFYLLDFILALVGNTLALWLFIRDHKSGTPANVFLMHLAVADLSCVLVLPTRLVYHFSGNHWPFGEIACRLTGFLFYLNMYASIYFLTCISADRFLAIVHPVKSLKLRRPLYAHLACAFLWVVVAVAMAPLLVSPQTVQTNHTVVCLQLYREKASHHALVSLAVAFTFPFITTVTCYLLIIRSLRQGLRVEKRLKTKAVRMIAIVLAIFLVCFVPYHVNRSVYVLHYRSHGASCATQRILALANRITSCLTSLNGALDPIMYFFVAEKFRHALCNLLCGKRLKGPPPSFEGKTNESSLSAKSEL
  
Inhibitor
Name:
BDBM646601
Synonyms:
6-chloro-7- (difluoromethylthio)-N-[5-(2- fluoroethoxy)-4,6-dimethoxy- pyrimidin-2-yl]-1H-indole-3- sulfonamide | US20240025883, Example 106
Type:
Small organic molecule
Emp. Form.:
C17H16ClF3N4O5S2
Mol. Mass.:
512.911
SMILES:
COc1nc(NS(=O)(=O)c2c[nH]c3c(SC(F)F)c(Cl)ccc23)nc(OC)c1OCCF
Structure:
Search PDB for entries with ligand similarity: